Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients

Clinical trial NCT07070752 · COMPLETED

Trial details

NCT number: NCT07070752
Sponsor: Geropharm
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitis

Start date: 2023-04-14
Primary completion: 2023-11-28
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.